Comments
Loading...

BridgeBio Pharma (BBIO) Stock Price, Quote, News & History

BBIONASDAQ
Logo brought to you by Benzinga Data
$74.48
-0.67-0.89%
Last update: Dec 15, 3:04 PM
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

3
Aug
4
Sep
9
Oct
3
Nov
1
Dec
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
$74.96
Close
-
Volume / Avg.
1.33M / 2.29M
Day Range
$73.95 - $75.61
52 Wk Range
25.34 - 75.24
Market Cap
$14.35B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
66
Short Interest
16.79%
Days to Cover
8.49

About

Sector
Health Care
Industry
Biotechnology
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disor...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BBIO
ONC

FAQ

Q

How do I buy BridgeBio Pharma (BBIO) stock?

A

You can purchase shares of BridgeBio Pharma (NASDAQ:BBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BridgeBio Pharma (BBIO) competitors?

Q

What is the forecast, or price target, for BridgeBio Pharma (BBIO) stock?

A

BridgeBio Pharma has a consensus price target of $66.56.

Q

What is the current price for BridgeBio Pharma (BBIO)?

A

The stock price for BridgeBio Pharma (NASDAQ: BBIO) is $74.48 last updated December 15, 2025 at 3:04 PM EST.

Q

Does BridgeBio Pharma (BBIO) pay a dividend?

A

There are no upcoming dividends for BridgeBio Pharma.

Q

When is BridgeBio Pharma (NASDAQ:BBIO) reporting earnings?

A

BridgeBio Pharma does not have any upcoming earnings scheduled.

Q

Is BridgeBio Pharma (BBIO) going to split?

A

There is no upcoming split for BridgeBio Pharma.

Q

What sector and industry does BridgeBio Pharma (BBIO) operate in?

A

BridgeBio Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.